Mitomycin C Resistance in a Human Colon Carcinoma Cell Line Associated with Cell Surface Protein Alterations

James K.V. Willson, Michael E. Marks, Diane E. Brattato, Byron H. Long, Michael G. Brattain, John E. Wiley

Research output: Contribution to journalArticle

37 Scopus citations

Abstract

A human colon carcinoma cell line resistant to mitomycin C (MMC) was obtained by repeated exposure of a previously described sensitive parental line, HCT 116, to MMC in vitro. Xenografts grown from the MMC-resistant phenotype were not inhibited in MMC-treated animals, while MMC treatment produced growth inhibition in parental cell xenografts. The MMC-resistant phenotype exhibited a greater amount of a Mr 148,000 cell surface protein than did the parental line. The increase in this M, 148,000 cell surface protein correlated positively with the degree of MMC resistance. Alkaline elution of filter-bound DNA from resistant cells exposed to MMC in vitro showed a decrease in DNA cross-link formation such that a 10-fold higher MMC concentration was required to produce similar cross-link formation in the resistant cell as compared to the parental cell. The development of MMC resistance was not associated with in vitro cross-resistance to other natural product cytotoxic drugs. This model for resistance to MMC will be useful in future studies to define the mechanisms for MMC action and resistance in human colon carcinoma cells.

Original languageEnglish (US)
Pages (from-to)5880-5885
Number of pages6
JournalCancer Research
Volume44
StatePublished - Dec 1 1984

ASJC Scopus subject areas

  • Oncology
  • Cancer Research

Fingerprint Dive into the research topics of 'Mitomycin C Resistance in a Human Colon Carcinoma Cell Line Associated with Cell Surface Protein Alterations'. Together they form a unique fingerprint.

  • Cite this

    Willson, J. K. V., Marks, M. E., Brattato, D. E., Long, B. H., Brattain, M. G., & Wiley, J. E. (1984). Mitomycin C Resistance in a Human Colon Carcinoma Cell Line Associated with Cell Surface Protein Alterations. Cancer Research, 44, 5880-5885.